| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO | Director
2 companies
Bentsur Ron serves as a Chairman &CEO at NVCT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 78 buys and 28 sells. Those positions are worth an estimated $83.7M at current prices.
Historically, Bentsur Ron's trades have earned a middling insider score of 64/100 across 73 rated trades. Over a 12-month horizon, 52.8% of those trades were profitable, with an average 12-month return of +6.6%.
The biggest single holding is NVCT (~$82.9M) as Chairman &CEO. Net of sales, the recent Form 4 record there shows accumulation of 392,965 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,200 | $16.73 | $20,070.00 | - | -43.3% | +9.6% | |
| May 18, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 2,010 | $19.48 | $39,155.30 | - | -51.4% | -10.7% | |
| May 16, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,700 | $18.82 | $31,990.00 | - | -51.1% | -11.1% | |
| May 12, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 12,245 | $16.99 | $208,046.70 | +0.1% | -53.2% | -10.5% | |
| Mar 28, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 4,000 | $7.05 | $28,200.00 | +0.1% | +76.4% | +75.2% | |
| Mar 17, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 7,000 | $7.63 | $53,410.00 | +0.2% | +33.2% | +56.6% | |
| Feb 14, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 8,000 | $5.88 | $47,040.00 | +0.3% | +251.2% | +97.8% | |
| Feb 10, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 8,500 | $6.34 | $53,890.00 | +0.3% | +157.6% | +133.3% | |
| Feb 7, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 232,500 | $4.96 | $1,153,145.00 | +2.1% | +89.4% | +37.0% | |
| Nov 24, 2021 | XAIR Beyond Air, Inc. | Director | Sell | 37,464 | $13.53 | $507,071.36 | -9.2% | -46.6% | -57.2% |